{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T17:15:38Z","timestamp":1719940538922},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T00:00:00Z","timestamp":1613606400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T00:00:00Z","timestamp":1613606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s00108-021-00972-8","type":"journal-article","created":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T15:47:09Z","timestamp":1613749629000},"page":"245-251","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Hyperaldosteronismus"],"prefix":"10.1007","volume":"62","author":[{"given":"U. I.","family":"Scholl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,18]]},"reference":[{"key":"972_CR1","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1210\/jc.2016-3821","volume":"102","author":"AH Ahmed","year":"2017","unstructured":"Ahmed\u00a0AH, Gordon\u00a0RD, Ward\u00a0G et\u00a0al (2017) Effect of moxonidine on the aldosterone\/Renin ratio in healthy male volunteers. J\u00a0Clin Endocrinol Metab 102:2039\u20132043","journal-title":"J Clin Endocrinol Metab"},{"key":"972_CR2","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/ng.2550","volume":"45","author":"F Beuschlein","year":"2013","unstructured":"Beuschlein\u00a0F, Boulkroun\u00a0S, Osswald\u00a0A et al (2013) Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension. Nat Genet 45:440\u2013444","journal-title":"Nat Genet"},{"key":"972_CR3","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1210\/jc.2008-2116","volume":"94","author":"E Born-Frontsberg","year":"2009","unstructured":"Born-Frontsberg\u00a0E, Reincke\u00a0M, Rump\u00a0LC et al (2009) Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn\u2019s Registry. J\u00a0Clin Endocrinol Metab 94:1125\u20131130","journal-title":"J Clin Endocrinol Metab"},{"key":"972_CR4","doi-asserted-by":"publisher","first-page":"630","DOI":"10.7326\/M17-0882","volume":"167","author":"JM Brown","year":"2017","unstructured":"Brown\u00a0JM, Robinson-Cohen\u00a0C, Luque-Fernandez\u00a0MA et al (2017) The spectrum of subclinical primary aldosteronism and incident hypertension: a cohort study. Ann Intern Med 167:630\u2013641","journal-title":"Ann Intern Med"},{"key":"972_CR5","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1126\/science.1198785","volume":"331","author":"M Choi","year":"2011","unstructured":"Choi\u00a0M, Scholl\u00a0UI, Yue\u00a0P et al (2011) K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science 331:768\u2013772","journal-title":"Science"},{"key":"972_CR6","first-page":"3","volume":"45","author":"JW Conn","year":"1955","unstructured":"Conn\u00a0JW (1955) Presidential address. I. Painting background. II. Primary aldosteronism, a\u00a0new clinical syndrome. J\u00a0Lab Clin Med 45:3\u201317","journal-title":"J Lab Clin Med"},{"key":"972_CR7","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S2213-8587(16)30100-0","volume":"4","author":"T Dekkers","year":"2016","unstructured":"Dekkers\u00a0T, Prejbisz\u00a0A, Kool\u00a0LJS et al (2016) Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial. Lancet Diabetes Endocrinol 4:739\u2013746","journal-title":"Lancet Diabetes Endocrinol"},{"key":"972_CR8","doi-asserted-by":"publisher","first-page":"K37","DOI":"10.1530\/EJE-19-0377","volume":"181","author":"RK Dutta","year":"2019","unstructured":"Dutta\u00a0RK, Arnesen\u00a0T, Heie\u00a0A et al (2019) A somatic mutation in CLCN2 identified in a\u00a0sporadic aldosterone-producing adenoma. Eur J Endocrinol 181:K37\u2013K41","journal-title":"Eur J Endocrinol"},{"key":"972_CR9","doi-asserted-by":"publisher","first-page":"e2016209","DOI":"10.1001\/jamanetworkopen.2020.16209","volume":"3","author":"G Eisenhofer","year":"2020","unstructured":"Eisenhofer\u00a0G, Duran\u00a0C, Cannistraci\u00a0CV et\u00a0al (2020) Use of steroid profiling combined with machine learning for identification and subtype classification in primary Aldosteronism. JAMA Netw Open 3:e2016209","journal-title":"JAMA Netw Open"},{"key":"972_CR10","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"Funder\u00a0JW, Carey\u00a0RM, Mantero\u00a0F et\u00a0al (2016) The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J\u00a0Clin Endocrinol Metab 101:1889\u20131916","journal-title":"J Clin Endocrinol Metab"},{"key":"972_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","volume":"6","author":"GL Hundemer","year":"2018","unstructured":"Hundemer\u00a0GL, Curhan\u00a0GC, Yozamp\u00a0N et\u00a0al (2018) Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a\u00a0retrospective cohort study. Lancet Diabetes Endocrinol 6:51\u201359","journal-title":"Lancet Diabetes Endocrinol"},{"key":"972_CR12","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1210\/jc.2018-01324","volume":"104","author":"I Laurent","year":"2019","unstructured":"Laurent\u00a0I, Astere\u00a0M, Zheng\u00a0F et al (2019) Adrenal venous sampling with or without adrenocorticotropic hormone stimulation: a meta-analysis. J\u00a0Clin Endocrinol Metab 104:1060\u20131068","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"972_CR13","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/355262a0","volume":"355","author":"RP Lifton","year":"1992","unstructured":"Lifton\u00a0RP, Dluhy\u00a0RG, Powers\u00a0M et al (1992) A chimaeric 11 beta-hydroxylase\/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 355:262\u2013265","journal-title":"Nature"},{"key":"972_CR14","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1210\/jc.2012-3353","volume":"98","author":"A Markou","year":"2013","unstructured":"Markou\u00a0A, Pappa\u00a0T, Kaltsas\u00a0G et\u00a0al (2013) Evidence of primary aldosteronism in a\u00a0predominantly female cohort of normotensive individuals: a\u00a0very high odds ratio for progression into arterial hypertension. J\u00a0Clin Endocrinol Metab 98:1409\u20131416","journal-title":"J Clin Endocrinol Metab"},{"key":"972_CR15","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","volume":"45","author":"P Milliez","year":"2005","unstructured":"Milliez\u00a0P, Girerd\u00a0X, Plouin\u00a0PF et\u00a0al (2005) Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J\u00a0Am Coll Cardiol 45:1243\u20131248","journal-title":"J Am Coll Cardiol"},{"key":"972_CR16","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","volume":"69","author":"S Monticone","year":"2017","unstructured":"Monticone\u00a0S, Burrello\u00a0J, Tizzani\u00a0D et\u00a0al (2017) Prevalence and clinical manifestations of primary Aldosteronism encountered in primary care practice. J\u00a0Am Coll Cardiol 69:1811\u20131820","journal-title":"J Am Coll Cardiol"},{"key":"972_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","volume":"6","author":"S Monticone","year":"2018","unstructured":"Monticone\u00a0S, D\u2019ascenzo\u00a0F, Moretti\u00a0C et al (2018) Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a\u00a0systematic review and meta-analysis. Lancet Diabetes Endocrinol 6:41\u201350","journal-title":"Lancet Diabetes Endocrinol"},{"key":"972_CR18","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1530\/ERC-18-0385","volume":"26","author":"IC Mouat","year":"2019","unstructured":"Mouat\u00a0IC, Omata\u00a0K, Mcdaniel\u00a0AS et\u00a0al (2019) Somatic mutations in adrenocortical carcinoma with primary aldosteronism or hyperreninemic hyperaldosteronism. Endocr Relat Cancer 26:217\u2013225","journal-title":"Endocr Relat Cancer"},{"key":"972_CR19","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1161\/HYPERTENSIONAHA.119.14349","volume":"75","author":"K Nanba","year":"2020","unstructured":"Nanba\u00a0K, Blinder\u00a0AR, Rege\u00a0J et al (2020) Somatic CACNA1H mutation as a\u00a0cause of Aldosterone-producing adenoma. Hypertension 75:645\u2013649","journal-title":"Hypertension"},{"key":"972_CR20","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1210\/jc.2018-01004","volume":"103","author":"K Nanba","year":"2018","unstructured":"Nanba\u00a0K, Omata\u00a0K, Else\u00a0T et al (2018) Targeted molecular characterization of aldosterone-producing adenomas in white Americans. J\u00a0Clin Endocrinol Metab 103:3869\u20133876","journal-title":"J Clin Endocrinol Metab"},{"key":"972_CR21","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1161\/HYPERTENSIONAHA.118.12070","volume":"73","author":"K Nanba","year":"2019","unstructured":"Nanba\u00a0K, Omata\u00a0K, Gomez-Sanchez\u00a0CE et al (2019) Genetic characteristics of aldosterone-producing adenomas in blacks. Hypertension 73:885\u2013892","journal-title":"Hypertension"},{"key":"972_CR22","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1210\/jc.2009-2010","volume":"95","author":"K Nishimoto","year":"2010","unstructured":"Nishimoto\u00a0K, Nakagawa\u00a0K, Li\u00a0D et\u00a0al (2010) Adrenocortical zonation in humans under normal and pathological conditions. J\u00a0Clin Endocrinol Metab 95:2296\u20132305","journal-title":"J Clin Endocrinol Metab"},{"key":"972_CR23","doi-asserted-by":"publisher","first-page":"E4591","DOI":"10.1073\/pnas.1505529112","volume":"112","author":"K Nishimoto","year":"2015","unstructured":"Nishimoto\u00a0K, Tomlins\u00a0SA, Kuick\u00a0R et al (2015) Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands. Proc Natl Acad Sci U S\u00a0A 112:E4591\u2013E4599","journal-title":"Proc Natl Acad Sci U S A"},{"key":"972_CR24","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1161\/HYPERTENSIONAHA.118.11086","volume":"72","author":"K Omata","year":"2018","unstructured":"Omata\u00a0K, Satoh\u00a0F, Morimoto\u00a0R et\u00a0al (2018) Cellular and genetic causes of idiopathic hyperaldosteronism. Hypertension 72:874\u2013880","journal-title":"Hypertension"},{"key":"972_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/jhh.2012.27","volume":"27","author":"E Pimenta","year":"2013","unstructured":"Pimenta\u00a0E, Gordon\u00a0RD, Stowasser\u00a0M (2013) Salt, aldosterone and hypertension. J\u00a0Hum Hypertens 27:1\u20136","journal-title":"J Hum Hypertens"},{"key":"972_CR26","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","volume":"48","author":"GP Rossi","year":"2006","unstructured":"Rossi\u00a0GP, Bernini\u00a0G, Caliumi\u00a0C et\u00a0al (2006) A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J\u00a0Am Coll Cardiol 48:2293\u20132300","journal-title":"J Am Coll Cardiol"},{"key":"972_CR27","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1161\/HYPERTENSIONAHA.119.13463","volume":"74","author":"GP Rossi","year":"2019","unstructured":"Rossi\u00a0GP, Rossitto\u00a0G, Amar\u00a0L et\u00a0al (2019) Clinical outcomes of 1625 patients with primary aldosteronism subtyped with adrenal vein sampling. Hypertension 74:800\u2013808","journal-title":"Hypertension"},{"key":"972_CR28","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1038\/ng.2695","volume":"45","author":"UI Scholl","year":"2013","unstructured":"Scholl\u00a0UI, Goh\u00a0G, Stolting\u00a0G et al (2013) Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism. Nat Genet 45:1050\u20131054","journal-title":"Nat Genet"},{"key":"972_CR29","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.06315","author":"UI Scholl","year":"2015","unstructured":"Scholl\u00a0UI, Stolting\u00a0G, Nelson-Williams\u00a0C et al (2015) Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism. Elife. https:\/\/doi.org\/10.7554\/eLife.06315","journal-title":"Elife"},{"key":"972_CR30","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41588-018-0048-5","volume":"50","author":"UI Scholl","year":"2018","unstructured":"Scholl\u00a0UI, Stolting\u00a0G, Schewe\u00a0J et\u00a0al (2018) CLCN2 chloride channel mutations in familial hyperaldosteronism type II. Nat Genet 50:349\u2013354","journal-title":"Nat Genet"},{"key":"972_CR31","doi-asserted-by":"publisher","first-page":"4113","DOI":"10.1210\/jc.2018-01394","volume":"103","author":"M Stowasser","year":"2018","unstructured":"Stowasser\u00a0M, Ahmed\u00a0AH, Cowley\u00a0D et\u00a0al (2018) Comparison of seated with recumbent saline suppression testing for the diagnosis of primary aldosteronism. J\u00a0Clin Endocrinol Metab 103:4113\u20134124","journal-title":"J Clin Endocrinol Metab"},{"key":"972_CR32","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3389\/fped.2014.00089","volume":"2","author":"P Trnka","year":"2014","unstructured":"Trnka\u00a0P, Orellana\u00a0L, Walsh\u00a0M et al (2014) Reninoma: an uncommon cause of Renin-mediated hypertension. Front Pediatr 2:89","journal-title":"Front Pediatr"},{"key":"972_CR33","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/S0140-6736(15)00257-3","volume":"386","author":"B Williams","year":"2015","unstructured":"Williams\u00a0B, Macdonald\u00a0TM, Morant\u00a0S et al (2015) Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a\u00a0randomised, double-blind, crossover trial. Lancet 386:2059\u20132068","journal-title":"Lancet"},{"key":"972_CR34","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","volume":"5","author":"TA Williams","year":"2017","unstructured":"Williams\u00a0TA, Lenders\u00a0JWM, Mulatero\u00a0P et\u00a0al (2017) Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol 5:689\u2013699","journal-title":"Lancet Diabetes Endocrinol"},{"key":"972_CR35","first-page":"1182","volume":"102","author":"Y Yamazaki","year":"2017","unstructured":"Yamazaki\u00a0Y, Nakamura\u00a0Y, Omata\u00a0K et al (2017) Histopathological classification of cross-sectional image-negative hyperaldosteronism. J\u00a0Clin Endocrinol Metab 102:1182\u20131192","journal-title":"J Clin Endocrinol Metab"},{"key":"972_CR36","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/joim.12831","volume":"285","author":"WF Young Jr.","year":"2019","unstructured":"Young\u00a0WF Jr. (2019) Diagnosis and treatment of primary aldosteronism: practical clinical perspectives. J\u00a0Intern Med 285:126\u2013148","journal-title":"J Intern Med"},{"key":"972_CR37","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1161\/HYPERTENSIONAHA.114.03346","volume":"65","author":"FF Zheng","year":"2015","unstructured":"Zheng\u00a0FF, Zhu\u00a0LM, Nie\u00a0AF et al (2015) Clinical characteristics of somatic mutations in Chinese patients with aldosterone-producing adenoma. Hypertension 65:622\u2013628","journal-title":"Hypertension"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-021-00972-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-021-00972-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-021-00972-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T12:14:35Z","timestamp":1614255275000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-021-00972-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,18]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["972"],"URL":"https:\/\/doi.org\/10.1007\/s00108-021-00972-8","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,18]]},"assertion":[{"value":"26 January 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"U.I.\u00a0Scholl gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von der Autorin keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}